Empirical Evaluation of the effect of a diseasespecific advance directive on the transfer of the presumed patient's wishes to the physician in a randomised, prospective intervention trial o patients with non small cell lung cancer in consideration of ethical aspects

Empirical Evaluation of the effect of a diseasespecific advance directive on the transfer of the presumed patient's wishes to the physician in a randomised, prospective intervention trial o patients with non small cell lung cancer in consideration of ethical aspects - SpezPat

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00017580

Enrollment

Registered

2019-08-27

Start date

2019-08-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advance directive

Interventions

Group 1: patients with common advance directive course of the study Participants are randomised into two groups. The intervention group will be provided with a diseasespecific advance directive and

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: inclusion criteria - diagnosed non small cell lung cancer stadium IV - of age (= 18 years) - capable of giving informed consent - gave informed to consent to participate in study - capable of understanding the aim and design of the study and able to participate - capable of uncerstanding and completing the questionniares used in this study - adequate command of spoken and written German - willingness to draft advance directive in study context

Exclusion criteria

Exclusion criteria: exclusion criteria - incapable of giving informed consent - diagnosed with other acitve maliginancies

Design outcomes

Primary

Measure	Time frame
To test the probablity of a match between the presumed patient's wish and the actual patient's wish in controll group and intervention group on significancy a logistic regression with intervantion as factor will be performed. Two more logistic regressions with intervention and physician and intervention and szenario as factors will be performed to find differences in evaluation between physician and scenario. - logistic regression double sided with 5 % as statistically significant - analysis of intention to treat population - descriptive summary of patients' characteristics age, gender, religiouness and having or not having children	—

Measure

Time frame

To test the probablity of a match between the presumed patient's wish and the actual patient's wish in controll group and intervention group on significancy a logistic regression with intervantion as factor will be performed. Two more logistic regressions with intervention and physician and intervention and szenario as factors will be performed to find differences in evaluation between physician and scenario. - logistic regression double sided with 5 % as statistically significant - analysis of intention to treat population - descriptive summary of patients' characteristics age, gender, religiouness and having or not having children

—

Countries

Germany

Contacts

Public ContactJulia König

Universitätsmedizin GöttingenKlinik für Hämatologie und medizinische Onkologie

julia.koenig@med.uni-goettingen.de015153390451

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 11, 2026